Benign Prostatic Hyperplasia

Benign prostate hyperplasia (BPH) and prostate cancer share a few similarities, elevated prostate-specific antigen (PSA). Along with enlargement of prostate gland that causes urinary symptoms such as, frequent urination, hesitancy, dribbling, and frequent nighttime urination. However, they are quite different which is why more tests need to be done to confirm one or the other condition. These two diseases are also similar in the fact that they both cause an enlargement of the prostate. However with BPH the central portion of the prostate is enlarged and with prostate cancer more commonly the lateral lobes or side of the prostate are enlarged, but can affect any were on the prostate. Both can even be detected by a digital rectal exam however

Cystoscopy dated 10/15/2014 showed a mild prostatic hyperplasia. The bladder had a mild to moderate trabeculations.

PSA levels are found increased in these conditions, as the tissue barrier is disrupted between the prostate gland lumen and the capillaries. PSA screening has limited accuracy, which can lead to over diagnosis of the disease, performance of unnecessary diagnostic testing and treatment. Therefore, many men with false positive PSA screening, who have no cancer, are subjected to invasive procedures such as prostate biopsies, radical prostatectomy and radiation therapy. Biopsies not only cause discomfort to the patient, but have other risks such as infections, hematuria, prostatitis, sepsis, endocarditis, cystitis, hypotension and urinary symptoms. The pros and cons of PSA testing should be informed to patient before performing the test. For these reasons, professional organizations, including the US Preventive Services Task Force (USPSTF), American Cancer Society (ACS), and American Urology Association (AUA), have issued clinical practice guidelines recommending that clinicians inform patients about the pros, cons, and uncertainties of PSA screening, and that screening decisions be based on patient preferences (Han

Many studies have been conducted to evaluate prostate screening. The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, which NCI conducted to establish whether certain screening tests can help reduce the numbers of deaths from several common cancers. In the prostate section of the trial, the PSA test and digital rectal exam(DRE) were evaluated for their ability to decrease a man’s chances of dying from prostate cancer.

Peter, a 72-year-old male, has been admitted for a transurethral resection of the prostate gland. Peter first visited his doctor a week ago after noticing it was becoming increasingly more difficult to pass urine and was only able to void small amounts with each attempt. Peter describes that he always feels as if he has a full bladder. What is likely to be wrong with Peter and what are his treatment options?

A thorough assessment of the patient’s perception of his overall health should be done. The patient should be educated on his current medical conditions and what each condition means, and how it affects the body. Since this patient's PSA is 6.0, it is above the normal range. Although, there is no specific normal or abnormal level of PSA in the blood. However, more recent studies have shown that men with PSA below 4.0 ng/ml have prostate cancer (NCI, 2012). And many men with higher levels do not have prostate cancer. I will refer this patient to a urologist. Urologist will do a further work up on him. This pt needs some education about his pending diagnoses.

Is urinating suddenly very difficult for you? Do you find yourself getting up several times a night to go to the toilet? Are your trips to the loo filled with dread and anxiety? Chances are, you are suffering from benign prostatic hyperplasia or BPH. We at Himex Labs know what you have to go through and – trust us – we understand. This is why we are offering Prostara, a proactive prostate support formulated to combat the symptoms of BPH.

Most of the doctors recommended removal of the enlarged part of the prostate as the best long term solution for the patients with BPH, only the enlarged tissues that is pressing against the urethra is removed , the rest of the inside tissues and outside capsule are left intact. Surgery usually relives the obstruction and incomplete emptying caused by BPH. The following section describes the type of surgery that is

At least be a combination of androgens in prostate tissue and age. An alteration in normal tissue promotes inflammation, caused by hyperplasia. This leads to enlargement a prostate lands and turn causing obstruction in bladder. I will try to compensate by thinking of bladder muscles to help excrete urine from the body. Despite the body trying to make adjustments there is increased urine residual left and chronic urinary retention. Should this be left to continue patients could experience hydroureter and hydronephrosis related to dilation of the ureters. (Ignatavicius, pg.1630

However when sexual dysfunctions are treated the dysfunctions typically will begin to dissipate. The individual may feel more aroused and the urge for sexual fulfillment. These results will vary depending on the treatment plan that is put in place by the physician and the patient. Some treatments can induce permanent recoveries, and others may only offer situational cures (such as Viagra).

Complications that can result from urethral injuries include infection, bleeding, permanent narrowing (stricture), erectile dysfunction, and uncontrollable loss of urine (urinary incontinence).The most common symptoms include blood at the tip of the penis in men or the urethral opening in women, blood in the urine, an inability to urinate, and pain during urination. Bruising may be visible between the legs or in the penis. Other symptoms may arise when complications develop. For example, if urine leaks into surrounding tissues, infection may result. In addition, the injury may cause the urethra to narrow (stricture) near or at the site of injury. Men may also experience impairment in the ability to have an erection (erectile dysfunction),

Prostate cancer affects the urethra and the bladder. That is why men who have prostate cancer are likely to have urinary problems. They may have to get up frequently in the middle of night to go to the restroom. It is also common for a man with prostate cancer to experience a burning sensation while urinating.

There are no consistent or obvious signs of prostate cancer while it is still in the early

All the discussed symptoms are collectively known as lower urinary tract symptoms (LUTS). Symptoms develops gradual and worsen over time. Complications associated with BPH include bloody urine, bladder or kidney infection, bladder stones, hydronephrosis, and renal insufficiency (Buttaro et al., 2013).

A blood test that tests for prostate-specific antigen (PSA) may also be done. Normally a small amount of PSA is in the blood for healthy men; a higher amount can indicate abnormalities with the prostate. The PSA combined with the DRE test has the highest rate of discovering prostate cancer in its early stages.